Catalytic [6 + 3] cycloaddition for the synthesis of medium-sized ring systems: a critical review. [PDF]
Archna +4 more
europepmc +1 more source
Venetoclax-Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE): Implications for Diagnosis and Treatment Continuation. [PDF]
Tanaka N, Iso A, Higashime A.
europepmc +1 more source
Pseudo-Richter transformation in a patient with chronic lymphocytic leukemia after cessation of fixed duration venetoclax/ibrutinib treatment. [PDF]
Battegay R, Heim D, Dirnhofer S.
europepmc +1 more source
Comment on AlAsmari et al. Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 6260. [PDF]
Trela BA, Guffroy MR.
europepmc +1 more source
Where next for BTKi-BCL2i combinations in mantle cell lymphoma? [PDF]
Eyre TA.
europepmc +1 more source
Bridged scaffold editing of carbocycles and heterocycles. [PDF]
Li J +7 more
europepmc +1 more source
Synthesis of aryl-fused bicyclo[3.1.1]heptanes and validation as naphthyl bioisosteres. [PDF]
Kerckhoffs A +12 more
europepmc +1 more source
Accessing Medium-Sized Bridged Heterocycles via EnT-Catalyzed Intermolecular Dearomative (5 + 4) Cycloaddition of Furans and Oxazoles. [PDF]
Hümpel C +5 more
europepmc +1 more source
Recent developments in the organocatalytic asymmetric cycloaddition/annulation reactions involving indolylmethanols. [PDF]
Patel A, Harshit, Iype E, Kumar I.
europepmc +1 more source

